Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration

NCT05618457 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Aminoglycoside Dosing Based on PK/PD Characteristics

Interventions

DRUG: Aminoglycoside dose adjustment

Sponsor

Hadassah Medical Organization